Zhao X - Search Results

1

Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.

Zhao J, Xu N, Zhu S, Nie L, Zhang M, Zheng L, Cai D, Sun X, Chen J, Dai J, Ni Y, Wang Z, Zhang X, Liang J, Chen Y, Hu X, Pan X, Yin X, Liu H, Zhao F, Zhang B, Chen H, Miao J, Qin C, Zhao X, Yao J, Liu Z, Liao B, Wei Q, Li X, Liu J, Gao AC, Huang H, Shen P, Chen N, Zeng H, Sun G. Zhao J, et al. Among authors: zhao x, zhao f. Cancer Res. 2024 Jan 2;84(1):154-167. doi: 10.1158/0008-5472.CAN-23-1176. Cancer Res. 2024. PMID: 37847513

2

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

Zhao J, Sun G, Zhu S, Dai J, Chen J, Zhang M, Ni Y, Zhang H, Shen P, Zhao X, Zhang B, Pan X, Nie L, Yin X, Liang J, Zhang X, Wang Z, Zhu X, Liao B, Liu Z, Armstrong CM, Gao AC, Huang H, Chen N, Zeng H. Zhao J, et al. Among authors: zhao x. BJU Int. 2022 Mar;129(3):345-355. doi: 10.1111/bju.15530. Epub 2021 Aug 3. BJU Int. 2022. PMID: 34185954

3

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).

Zhu S, Zhao J, Nie L, Yin W, Zhang Y, Zhao F, Ni Y, Zhang X, Wang Z, Dai J, Liu Z, Chen J, Zeng Y, Wang Z, Sun G, Liang J, Zhao X, Zhu X, Tao R, Yang J, He B, Chen N, Shen P, Zeng H. Zhu S, et al. Among authors: zhao j, zhao x, zhao f. BMC Med. 2022 Jul 22;20(1):237. doi: 10.1186/s12916-022-02430-0. BMC Med. 2022. PMID: 35864546 Free PMC article.

4

A novel 8-gene panel for prediction of early biochemical recurrence in patients with prostate cancer after radical prostatectomy.

Guo J, Zhao C, Zhang X, Wan Z, Chen T, Miao J, Cai J, Xie W, Chen H, Huang M, Zhao X, Wei W, Shen Q. Guo J, et al. Among authors: zhao x, zhao c. Am J Cancer Res. 2022 Jul 15;12(7):3318-3332. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968320 Free PMC article.

5

Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer.

Liao H, Cai S, Bai Y, Zhang B, Sheng Y, Tong S, Cai J, Zhao F, Zhao X, Chen S, Zhang C, Gao J. Liao H, et al. Among authors: zhao x, zhao f. Am J Cancer Res. 2021 Nov 15;11(11):5571-5580. eCollection 2021. Am J Cancer Res. 2021. PMID: 34873480 Free PMC article.

6

Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment.

Wang Z, Zhao X, Gao C, Gong J, Wang X, Gao J, Li Z, Wang J, Yang B, Wang L, Zhang B, Zhou Y, Wang D, Li X, Bai Y, Li J, Shen L. Wang Z, et al. Among authors: zhao x. J Immunother Cancer. 2020 Nov;8(2):e001297. doi: 10.1136/jitc-2020-001297. J Immunother Cancer. 2020. PMID: 33172882 Free PMC article.

7

Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.

Yue D, Liu W, Chen C, Zhang T, Ma Y, Cui L, Gu Y, Bei T, Zhao X, Zhang B, Bai Y, Romero A, Xu-Welliver M, Wang C, Zhang Z, Zhang B. Yue D, et al. Among authors: zhao x. Transl Lung Cancer Res. 2022 Feb;11(2):263-276. doi: 10.21037/tlcr-22-106. Transl Lung Cancer Res. 2022. PMID: 35280315 Free PMC article.

8

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer.

Chen Y, Wang X, Du F, Yue J, Si Y, Zhao X, Cui L, Zhang B, Bei T, Xu B, Yuan P. Chen Y, et al. Among authors: zhao x. Cancer Biol Med. 2023 Mar 2;20(2):155-68. doi: 10.20892/j.issn.2095-3941.2022.0525. Cancer Biol Med. 2023. PMID: 36861447 Free PMC article.

9

Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.

Gao G, Cui L, Zhou F, Jiang T, Wang W, Mao S, Wu F, Jiang F, Zhang B, Bei T, Xie W, Zhang C, Zhang H, Gao C, Zhao X, Bai Y, Zhou C, Ren S. Gao G, et al. Among authors: zhao x. Int J Cancer. 2023 Jan 1;152(1):79-89. doi: 10.1002/ijc.34239. Epub 2022 Sep 5. Int J Cancer. 2023. PMID: 36062503 Free article.

10

Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations.

Yang J, Wang X, Lu J, Chen H, Zhao X, Gao C, Bai Y, Zhang Q, Fu X, Zhang X. Yang J, et al. Among authors: zhao x. J Cancer. 2021 Jun 22;12(17):5099-5105. doi: 10.7150/jca.55134. eCollection 2021. J Cancer. 2021. PMID: 34335926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47,782 results

Search Page